TreeWAS – Variant ID: rs10737896

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I50.0 Congestive heart failure	0.029	0.971	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.972	0.028
E28.2 Polycystic ovarian syndrome	0.027	0.973	0.000
E28 Ovarian dysfunction	0.024	0.976	0.000
E22 Hyperfunction of pituitary gland	0.024	0.976	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.023	0.977	0.000
E22.0 Acromegaly and pituitary gigantism	0.022	0.978	0.000
E20-E35 Disorders of other endocrine glands	0.022	0.978	0.000
C67 Malignant neoplasm of bladder	0.000	0.980	0.020
C67.5 Bladder neck	0.000	0.980	0.020
E23 Hypofunction and other disorders of pituitary gland	0.019	0.981	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.981	0.019
C67.2 Lateral wall of bladder	0.000	0.981	0.019
E29 Testicular dysfunction	0.019	0.981	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.018	0.982	0.000
C67.0 Trigone of bladder	0.000	0.982	0.018
T39.0 Salicylates	0.000	0.982	0.018
E28.9 Ovarian dysfunction, unspecified	0.018	0.982	0.000
E28.8 Other ovarian dysfunction	0.018	0.982	0.000
E28.1 Androgen excess	0.018	0.982	0.000
E28.0 Oestrogen excess	0.018	0.982	0.000
E24 Cushing's syndrome	0.017	0.983	0.000
E28.3 Primary ovarian failure	0.017	0.983	0.000
E22.8 Other hyperfunction of pituitary gland	0.017	0.983	0.000
C67.1 Dome of bladder	0.000	0.983	0.017
E31 Polyglandular dysfunction	0.017	0.983	0.000
C67.6 Ureteric orifice	0.000	0.983	0.017
C67.3 Anterior wall of bladder	0.000	0.983	0.017
E23.2 Diabetes insipidus	0.017	0.983	0.000
C67.4 Posterior wall of bladder	0.000	0.983	0.017
E25 Adrenogenital disorders	0.016	0.983	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.016	0.984	0.000
E30 Disorders of puberty, not elsewhere classified	0.016	0.984	0.000
E32 Diseases of thymus	0.016	0.984	0.000
C67.8 Overlapping lesion of bladder	0.000	0.984	0.016
E26 Hyperaldosteronism	0.016	0.984	0.000
E29.9 Testicular dysfunction, unspecified	0.016	0.984	0.000
E23.0 Hypopituitarism	0.015	0.985	0.000
E29.1 Testicular hypofunction	0.015	0.985	0.000
C67.7 Urachus	0.000	0.985	0.015
E23.6 Other disorders of pituitary gland	0.015	0.985	0.000
E24.9 Cushing's syndrome, unspecified	0.015	0.985	0.000
E20 Hypoparathyroidism	0.014	0.985	0.000
E27 Other disorders of adrenal gland	0.014	0.986	0.000
E23.1 Drug-induced hypopituitarism	0.014	0.986	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.986	0.014
T39.4 Antirheumatics, not elsewhere classified	0.000	0.986	0.014
T39.2 Pyrazolone derivatives	0.000	0.986	0.014
E22.1 Hyperprolactinaemia	0.014	0.986	0.000
T39.1 4-Aminophenol derivatives	0.000	0.986	0.014
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.014	0.986	0.000
E34 Other endocrine disorders	0.014	0.986	0.000
E29.8 Other testicular dysfunction	0.014	0.986	0.000
E29.0 Testicular hyperfunction	0.014	0.986	0.000
E23.7 Disorder of pituitary gland, unspecified	0.013	0.986	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.987	0.013
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.013	0.987	0.000
E27.1 Primary adrenocortical insufficiency	0.013	0.987	0.000
E24.2 Drug-induced Cushing's syndrome	0.013	0.987	0.000
E31.0 Autoimmune polyglandular failure	0.013	0.987	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.013	0.987	0.000
E24.3 Ectopic ACTH syndrome	0.013	0.987	0.000
E24.1 Nelson's syndrome	0.013	0.987	0.000
E24.8 Other Cushing's syndrome	0.012	0.987	0.000
E26.9 Hyperaldosteronism, unspecified	0.012	0.987	0.000
S82.20 Fracture of shaft of tibia (closed)	0.000	0.988	0.012
E31.9 Polyglandular dysfunction, unspecified	0.012	0.988	0.000
E31.8 Other polyglandular dysfunction	0.012	0.988	0.000
E31.1 Polyglandular hyperfunction	0.012	0.988	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.012	0.988	0.000
E34.9 Endocrine disorder, unspecified	0.012	0.988	0.000
E25.9 Adrenogenital disorder, unspecified	0.012	0.988	0.000
E25.8 Other adrenogenital disorders	0.012	0.988	0.000
E30.9 Disorder of puberty, unspecified	0.012	0.988	0.000
E30.8 Other disorders of puberty	0.012	0.988	0.000
E30.1 Precocious puberty	0.012	0.988	0.000
E30.0 Delayed puberty	0.012	0.988	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.012	0.988	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.012	0.988	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.012	0.988	0.000
E32.9 Disease of thymus, unspecified	0.012	0.988	0.000
E32.1 Abscess of thymus	0.012	0.988	0.000
E32.0 Persistent hyperplasia of thymus	0.012	0.988	0.000
E32.8 Other diseases of thymus	0.011	0.988	0.000
E26.8 Other hyperaldosteronism	0.011	0.988	0.000
E26.1 Secondary hyperaldosteronism	0.011	0.988	0.000
C67.9 Bladder, unspecified	0.000	0.989	0.011
R59.1 Generalised enlarged lymph nodes	0.011	0.989	0.000
E27.2 Addisonian crisis	0.011	0.989	0.000
E21.3 Hyperparathyroidism, unspecified	0.011	0.989	0.000
E20.1 Pseudohypoparathyroidism	0.011	0.989	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.011	0.989	0.000
E21.4 Other specified disorders of parathyroid gland	0.011	0.989	0.000
E24.0 Pituitary-dependent Cushing's disease	0.010	0.989	0.000
E20.8 Other hypoparathyroidism	0.010	0.989	0.000
E20.0 Idiopathic hypoparathyroidism	0.010	0.989	0.000
E27.5 Adrenomedullary hyperfunction	0.011	0.989	0.000
E27.0 Other adrenocortical overactivity	0.011	0.989	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.010	0.990	0.000
E34.5 Androgen resistance syndrome	0.010	0.990	0.000
E34.4 Constitutional tall stature	0.010	0.990	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.010	0.990	0.000
E34.1 Other hypersecretion of intestinal hormones	0.010	0.990	0.000
E34.3 Short stature, not elsewhere classified	0.009	0.990	0.000
E26.0 Primary hyperaldosteronism	0.009	0.990	0.000
E21.2 Other hyperparathyroidism	0.009	0.991	0.000
E27.8 Other specified disorders of adrenal gland	0.008	0.991	0.000
E20.9 Hypoparathyroidism, unspecified	0.008	0.991	0.000
E27.9 Disorder of adrenal gland, unspecified	0.008	0.991	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.008	0.992	0.000
E34.8 Other specified endocrine disorders	0.007	0.992	0.000
M79.79 Fibromyalgia (Site unspecified)	0.008	0.992	0.000
E34.0 Carcinoid syndrome	0.007	0.993	0.000
G47.9 Sleep disorder, unspecified	0.000	0.993	0.007
E27.4 Other and unspecified adrenocortical insufficiency	0.007	0.993	0.000
Z93.6 Other artificial openings of urinary tract status	0.000	0.994	0.006
W10.8 Other specified place	0.000	0.994	0.006
Z47.8 Other specified orthopaedic follow-up care	0.000	0.994	0.006
L53.9 Erythematous condition, unspecified	0.000	0.995	0.005
N99.5 Malfunction of external stoma of urinary tract	0.000	0.995	0.005
W10 Fall on and from stairs and steps	0.000	0.995	0.005
N99.2 Postprocedural adhesions of vagina	0.000	0.995	0.005
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.995	0.005
W10.3 Sports and athletics area	0.000	0.995	0.004
E21.0 Primary hyperparathyroidism	0.004	0.996	0.000
R59 Enlarged lymph nodes	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.996	0.004
I31.9 Disease of pericardium, unspecified	0.004	0.996	0.000
W10.4 Street and highway	0.000	0.996	0.004
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.996	0.004
W10.6 Industrial and construction area	0.000	0.996	0.004
W10.1 Residential institution	0.000	0.996	0.004
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
R94.5 Abnormal results of liver function studies	0.000	0.996	0.004
C64-C68 Malignant neoplasms of urinary tract	0.000	0.996	0.004
S82.2 Fracture of shaft of tibia	0.000	0.996	0.004
I50 Heart failure	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.004
W10.9 Unspecified place	0.000	0.996	0.004
W10.5 Trade and service area	0.000	0.996	0.004
W10.2 School, other institution and public administrative area	0.000	0.996	0.004
W10.0 Home	0.000	0.996	0.004
W10.7 Farm	0.000	0.996	0.004
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.004
T46.1 Calcium-channel blockers	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
Z34.8 Supervision of other normal pregnancy	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.003
C66 Malignant neoplasm of ureter	0.000	0.996	0.003
T36 Poisoning by systemic antibiotics	0.000	0.996	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
I44.7 Left bundle-branch block, unspecified	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
I44.3 Other and unspecified atrioventricular block	0.003	0.997	0.000
R59.9 Enlarged lymph nodes, unspecified	0.003	0.997	0.000
R59.0 Localised enlarged lymph nodes	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
L85.8 Other specified epidermal thickening	0.003	0.997	0.000
T42.4 Benzodiazepines	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
G59.0 Diabetic mononeuropathy	0.000	0.997	0.003
N03.9 Unspecified	0.000	0.997	0.003
W10.08 Fall on and from stairs and steps; Home; While engaged in other specified activities	0.000	0.997	0.003
W10.04 Fall on and from stairs and steps; Home; While resting, sleeping, eating or engaging in other vital activities	0.000	0.997	0.003
W10.03 Fall on and from stairs and steps; Home; While engaged in other types of work	0.000	0.997	0.003
W10.29 Fall on and from stairs and steps; School, other institution and public administrative area; During unspecified activity	0.000	0.997	0.003
W10.59 Fall on and from stairs and steps; Trade and service area; During unspecified activity	0.000	0.997	0.003
W10.92 Fall on and from stairs and steps; Unspecified place; While working for income	0.000	0.997	0.003
W10.90 Fall on and from stairs and steps; Unspecified place; While engaged in sports activity	0.000	0.997	0.003
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.003	0.997	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.997	0.003
O04.9 Complete or unspecified, without complication	0.003	0.997	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.997	0.003
T36.4 Tetracyclines	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
L53 Other erythematous conditions	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.002
T41.4 Anaesthetic, unspecified	0.000	0.997	0.002
T41.3 Local anaesthetics	0.000	0.997	0.002
T41.1 Intravenous anaesthetics	0.000	0.997	0.002
T41.0 Inhaled anaesthetics	0.000	0.997	0.002
T50.8 Diagnostic agents	0.000	0.997	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.002
C65 Malignant neoplasm of renal pelvis	0.000	0.997	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.002
T42.3 Barbiturates	0.000	0.997	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.002
T37.5 Antiviral drugs	0.000	0.997	0.002
T37.4 Anthelminthics	0.000	0.997	0.002
T37.3 Other antiprotozoal drugs	0.000	0.997	0.002
T37.1 Antimycobacterial drugs	0.000	0.997	0.002
T37.0 Sulphonamides	0.000	0.997	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.002
W19.4 Street and highway	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.002
T50.5 Appetite depressants	0.000	0.997	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.002
T42.0 Hydantoin derivatives	0.000	0.997	0.002
M90.78 Fracture of bone in neoplastic disease (Other)	0.002	0.997	0.000
J81 Pulmonary oedema	0.003	0.997	0.000
M13.94 Arthritis, unspecified (Hand)	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.998	0.002
R76.8 Other specified abnormal immunological findings in serum	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
C68.8 Overlapping lesion of urinary organs	0.000	0.998	0.002
C68.1 Paraurethral glands	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
N99.1 Postprocedural urethral stricture	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
L53.0 Toxic erythema	0.000	0.998	0.002
S82.21 Fracture of shaft of tibia (open)	0.000	0.998	0.002
C68.0 Urethra	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
D48.1 Connective and other soft tissue	0.000	0.998	0.002
I44.6 Other and unspecified fascicular block	0.002	0.998	0.000
L53.3 Other chronic figurate erythema	0.000	0.998	0.002
L53.2 Erythema marginatum	0.000	0.998	0.002
L53.1 Erythema annulare centrifugum	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
M79.7 Fibromyalgia	0.002	0.998	0.000
C68.9 Urinary organ, unspecified	0.000	0.998	0.002
I44 Atrioventricular and left bundle-branch block	0.002	0.998	0.000
I31 Other diseases of pericardium	0.002	0.998	0.000
F50.2 Bulimia nervosa	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.002	0.998	0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.000	0.998	0.002
E11.4 With neurological complications	0.000	0.998	0.002
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.002	0.998	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.000	0.998	0.002
V18.0 Driver injured in nontraffic accident	0.000	0.998	0.002
N99.0 Postprocedural renal failure	0.000	0.998	0.002
I42.8 Other cardiomyopathies	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
L53.8 Other specified erythematous conditions	0.000	0.998	0.002
R87.6 Abnormal cytological findings	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
I15.1 Hypertension secondary to other renal disorders	0.002	0.998	0.000
M79.78 Fibromyalgia (Other)	0.002	0.998	0.000
M79.77 Fibromyalgia (Ankle and foot)	0.002	0.998	0.000
M79.76 Fibromyalgia (Lower leg)	0.002	0.998	0.000
M79.75 Fibromyalgia (Pelvic region and thigh)	0.002	0.998	0.000
M79.74 Fibromyalgia (Hand)	0.002	0.998	0.000
M79.73 Fibromyalgia (Forearm)	0.002	0.998	0.000
M79.72 Fibromyalgia (Upper arm)	0.002	0.998	0.000
M79.71 Fibromyalgia (Shoulder region)	0.002	0.998	0.000
I85.9 Oesophageal varices without bleeding	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.002	0.998	0.000
I34.1 Mitral (valve) prolapse	0.002	0.998	0.000
I44.5 Left posterior fascicular block	0.002	0.998	0.000
L71.9 Rosacea, unspecified	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
N99-N99 Other disorders of the genitourinary system	0.000	0.998	0.002
I31.8 Other specified diseases of pericardium	0.002	0.998	0.000
I31.2 Haemopericardium, not elsewhere classified	0.002	0.998	0.000
I44.1 Atrioventricular block, second degree	0.002	0.998	0.000
T45.4 Iron and its compounds	0.000	0.998	0.002
I31.3 Pericardial effusion (noninflammatory)	0.002	0.998	0.000
M90.7 Fracture of bone in neoplastic disease	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.998	0.002
G31.2 Degeneration of nervous system due to alcohol	0.000	0.998	0.002
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
N76.0 Acute vaginitis	0.002	0.998	0.000
V14.4 Driver injured in traffic accident	0.000	0.998	0.002
C18.6 Descending colon	0.002	0.998	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.998	0.002
I31.1 Chronic constrictive pericarditis	0.002	0.998	0.000
N03 Chronic nephritic syndrome	0.000	0.998	0.002
Z47 Other orthopaedic follow-up care	0.000	0.998	0.002
M90.71 Fracture of bone in neoplastic disease (Shoulder region)	0.002	0.998	0.000
C10.9 Oropharynx, unspecified	0.002	0.998	0.000
T40.5 Cocaine	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.001
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.002	0.998	0.000
N03.8 Other	0.000	0.998	0.002
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.002	0.998	0.000
I42.6 Alcoholic cardiomyopathy	0.002	0.998	0.000
I42 Cardiomyopathy	0.002	0.998	0.000
I42.9 Cardiomyopathy, unspecified	0.002	0.998	0.000
T40.3 Methadone	0.000	0.998	0.001
M90.76 Fracture of bone in neoplastic disease (Lower leg)	0.001	0.998	0.000
G80.1 Spastic diplegia	0.002	0.998	0.000
I31.0 Chronic adhesive pericarditis	0.001	0.998	0.000
I42.4 Endocardial fibroelastosis	0.002	0.998	0.000
I50.1 Left ventricular failure	0.002	0.998	0.000
R61.9 Hyperhidrosis, unspecified	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.001
T40.8 Lysergide [LSD]	0.000	0.998	0.001
T40.7 Cannabis (derivatives)	0.000	0.998	0.001
T40.0 Opium	0.000	0.998	0.001
M90.79 Fracture of bone in neoplastic disease (Site unspecified)	0.001	0.998	0.000
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)	0.001	0.998	0.000
M90.74 Fracture of bone in neoplastic disease (Hand)	0.001	0.998	0.000
M90.73 Fracture of bone in neoplastic disease (Forearm)	0.001	0.998	0.000
I44.4 Left anterior fascicular block	0.001	0.998	0.000
K92.9 Disease of digestive system, unspecified	0.000	0.998	0.002
N18.2 Chronic kidney disease, stage 2	0.000	0.998	0.002
O04.4 Incomplete, without complication	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.001
V19 Pedal cyclist injured in other and unspecified transport accidents	0.000	0.998	0.002
G30.8 Other Alzheimer's disease	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.000	0.998	0.001
G80.2 Infantile hemiplegia	0.001	0.998	0.000
R94.3 Abnormal results of cardiovascular function studies	0.000	0.998	0.002
Z47.9 Orthopaedic follow-up care, unspecified	0.000	0.998	0.001
I85.0 Oesophageal varices with bleeding	0.001	0.998	0.000
N41.1 Chronic prostatitis	0.000	0.998	0.002
F00 Dementia in Alzheimer's disease	0.000	0.998	0.002
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus	0.000	0.998	0.001
M90.72 Fracture of bone in neoplastic disease (Upper arm)	0.001	0.998	0.000
G80.0 Spastic cerebral palsy	0.001	0.998	0.000
K55.8 Other vascular disorders of intestine	0.000	0.998	0.001
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.001
G80 Infantile cerebral palsy	0.002	0.998	0.000
M90.70 Fracture of bone in neoplastic disease (Multiple sites)	0.001	0.998	0.000
S72.40 Fracture of lower end of femur (closed)	0.000	0.998	0.001
N03.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.001
N03.6 Dense deposit disease	0.000	0.998	0.001
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.998	0.001
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.998	0.001
N03.0 Minor glomerular abnormality	0.000	0.998	0.001
O20.0 Threatened abortion	0.000	0.998	0.001
O04 Medical abortion	0.001	0.998	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.999	0.001
F00.0 Dementia in Alzheimer's disease with early onset	0.000	0.999	0.001
T40.1 Heroin	0.000	0.999	0.001
I42.3 Endomyocardial (eosinophilic) disease	0.001	0.999	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.999	0.001
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.999	0.001
V18 Pedal cyclist injured in noncollision transport accident	0.000	0.999	0.001
O62.2 Other uterine inertia	0.000	0.999	0.001
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.001	0.999	0.000
V14.9 Unspecified pedal cyclist injured in traffic accident	0.000	0.999	0.001
G80.8 Other infantile cerebral palsy	0.001	0.999	0.000
N03.1 Focal and segmental glomerular lesions	0.000	0.999	0.001
L51.9 Erythema multiforme, unspecified	0.000	0.999	0.001
N03.2 Diffuse membranous glomerulonephritis	0.000	0.999	0.001
V19.9 Pedal cyclist [any] injured in unspecified traffic accident	0.000	0.999	0.001
V19.6 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.999	0.001
V19.2 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident	0.000	0.999	0.001
V19.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.999	0.001
V19.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.000	0.999	0.001
V19.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.000	0.999	0.001
S42.10 Fracture of scapula (closed)	0.001	0.999	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.001	0.999	0.000
M79.70 Fibromyalgia (Multiple sites)	0.001	0.999	0.000
I42.5 Other restrictive cardiomyopathy	0.001	0.999	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.999	0.001
V14.5 Passenger injured in traffic accident	0.000	0.999	0.001
V14.3 Person injured while boarding or alighting	0.000	0.999	0.001
V14.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.999	0.001
V14.1 Passenger injured in nontraffic accident	0.000	0.999	0.001
V14.0 Driver injured in nontraffic accident	0.000	0.999	0.001
G80.4 Ataxic cerebral palsy	0.001	0.999	0.000
G80.3 Dyskinetic cerebral palsy	0.001	0.999	0.000
M33.2 Polymyositis	0.000	0.999	0.001
M33.1 Other dermatomyositis	0.000	0.999	0.001
O04.7 Complete or unspecified, complicated by embolism	0.001	0.999	0.000
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.001	0.999	0.000
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.001	0.999	0.000
O04.3 Incomplete, with other and unspecified complications	0.001	0.999	0.000
O04.2 Incomplete, complicated by embolism	0.001	0.999	0.000
O04.0 Incomplete, complicated by genital tract and pelvic infection	0.001	0.999	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.999	0.001
S52.10 Fracture of upper end of radius (closed)	0.000	0.999	0.001
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.999	0.001
S11.9 Open wound of neck, part unspecified	0.001	0.999	0.000
S69.9 Unspecified injury of wrist and hand	0.000	0.999	0.001
G59 Mononeuropathy in diseases classified elsewhere	0.000	0.999	0.001
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.999	0.001
V18.9 Unspecified pedal cyclist injured in traffic accident	0.000	0.999	0.001
V18.4 Driver injured in traffic accident	0.000	0.999	0.001
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
N32.1 Vesicointestinal fistula	0.001	0.999	0.000
O04.8 Complete or unspecified, with other and unspecified complications	0.001	0.999	0.000
V18.1 Passenger injured in nontraffic accident	0.000	0.999	0.001
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.001	0.999	0.000
V19.29 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident; During unspecified activity	0.000	0.999	0.001
V19.69 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident: Unspecified place	0.000	0.999	0.001
V19.99 Pedal cyclist [any] injured in unspecified traffic accident; during unspecified activity	0.000	0.999	0.001
I60.8 Other subarachnoid haemorrhage	0.000	0.999	0.001
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.999	0.001
V19.8 Pedal cyclist [any] injured in other specified transport accidents	0.000	0.999	0.001
C32.0 Glottis	0.001	0.999	0.000
G51.9 Disorder of facial nerve, unspecified	0.001	0.999	0.000
V18.5 Passenger injured in traffic accident	0.000	0.999	0.001
I85 Oesophageal varices	0.001	0.999	0.000
R94 Abnormal results of function studies	0.000	0.999	0.001
L51 Erythema multiforme	0.000	0.999	0.001
V10-V19 Pedal cyclist injured in transport accident	0.000	0.999	0.001
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.000	0.999	0.001
G59.8 Other mononeuropathies in diseases classified elsewhere	0.000	0.999	0.001
I15.9 Seconday hypertension, unspecified	0.001	0.999	0.000
L71.8 Other rosacea	0.001	0.999	0.000
O62.9 Abnormality of forces of labour, unspecified	0.000	0.999	0.001
O62.3 Precipitate labour	0.000	0.999	0.001
R94.0 Abnormal results of function studies of central nervous system	0.000	0.999	0.001
T40.6 Other and unspecified narcotics	0.000	0.999	0.001
G30 Alzheimer's disease	0.000	0.999	0.001
V18.49 Pedal cyclist injured in noncollision transport accident; driver injured in traffic accident ; during unspecified activity	0.000	0.999	0.001
V18.99 Pedal cyclist injured in noncollision transport accident; unspecified pedal cyclist injured in traffic accident; during unspecified activity	0.000	0.999	0.001
V18.3 Person injured while boarding or alighting	0.000	0.999	0.001
F50 Eating disorders	0.000	0.999	0.001
I60 Subarachnoid haemorrhage	0.000	0.999	0.001
G30.0 Alzheimer's disease with early onset	0.000	0.999	0.001
O04.1 Incomplete, complicated by delayed or excessive haemorrhage	0.001	0.999	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.999	0.001
V13 Pedal cyclist injured in collision with car, pick-up truck or van	0.000	0.999	0.001
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.001	0.999	0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.999	0.001
M84.07 Malunion of fracture (Ankle and foot)	0.000	0.999	0.001
C49.2 Connective and soft tissue of lower limb, including hip	0.001	0.999	0.000
I15.0 Renovascular hypertension	0.001	0.999	0.000
L20.9 Atopic dermatitis, unspecified	0.000	0.999	0.001
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.000	0.999	0.001
V13.0 Driver injured in nontraffic accident	0.000	0.999	0.001
Y79.2 Prosthetic and other implants, materials and accessory devices	0.001	0.999	0.000
R17 Unspecified jaundice	0.000	0.999	0.001
M54.12 Radiculopathy (Cervical region)	0.000	0.999	0.001
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations